February 28, 2020 / 2:09 PM / a month ago

BRIEF-Medexus Expands Its US Product Portfolio By Acquiring The Hematology Asset Ixinity

Feb 28 (Reuters) - Medexus Pharmaceuticals Inc:

* MEDEXUS EXPANDS ITS US PRODUCT PORTFOLIO BY ACQUIRING THE HEMATOLOGY ASSET IXINITY®

* MEDEXUS PHARMACEUTICALS INC - ANNOUNCES US$20 MILLION CREDIT FACILITY WITH MIDCAP FINANCIAL

* MEDEXUS PHARMACEUTICALS INC - ACQUISITION EXPECTED TO BE IMMEDIATELY ACCRETIVE TO ADJUSTED EBITDA

* MEDEXUS PHARMACEUTICALS INC - DEAL FOR UP-FRONT CASH CONSIDERATION OF APPROXIMATELY US$30 MILLION

* MEDEXUS PHARMACEUTICALS - DEAL FINANCED ENTIRELY WITH EXISTING CASH, NEW US$20 MILLION TERM LOAN CREDIT FACILITY WITH MIDCAP FINANCIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below